Allogene Therapeutics
ALLO
ALLO
170 hedge funds and large institutions have $223M invested in Allogene Therapeutics in 2025 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 53 increasing their positions, 45 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
1% more funds holding
Funds holding: 169 → 170 (+1)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.68% less ownership
Funds ownership: 73.05% → 72.37% (-0.68%)
Holders
170
Holding in Top 10
4
Calls
$281K
Puts
$45K
Top Buyers
| 1 | +$3.04M | |
| 2 | +$2.61M | |
| 3 | +$1.43M | |
| 4 |
Primecap Management
Pasadena,
California
|
+$1.4M |
| 5 |
Jane Street
New York
|
+$1.25M |
Top Sellers
| 1 | -$2.88M | |
| 2 | -$2.45M | |
| 3 | -$2.04M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$1.49M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.38M |
